Article
First Case of Tap1 Deficiency With Ebv B-cell Lymphoma Treated With Cellular Immunotherapy
2025-09-09
Abstract excerpt
<title>Abstract</title> <p> <bold>Purpose:</bold> Bare Lymphocyte Syndrome (BLS) type I, due to mutations in TAP1, leads to impaired HLA class I expression and increased susceptibility to infections. EBV-driven lymphomas are rare in BLS patients. Here, we will expose the management of a TAP1 deficiency, and we will expose the possibility of treat an EBV-associated B cell lymphoma treated with cellular therapy....
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0ca02966-4d25-51cf-96d6-f6e0d6974423
- DOI
- 10.21203/rs.3.rs-7188387/v1
